Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)

NCT03736447 is registered in ClinicalTrials.gov with Aimmune Therapeutics, Inc. as lead sponsor.

NCT NCT03736447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)
Lead sponsor
Aimmune Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 27, 2018
Completion date
July 5, 2022
Enrollment
146 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

peanut allergy